Cotton wool spots

Last updated
An ophthalmoscopic view of the retina showing advanced signs of diabetic retinopathy including two pale cotton wool spots. Fundus Proliferative retinopathy EDA01.JPG
An ophthalmoscopic view of the retina showing advanced signs of diabetic retinopathy including two pale cotton wool spots.

Cotton wool spots are opaque fluffy white patches on the retina of the eye that are considered an abnormal finding during a funduscopic exam (also called an ophthalmoscopic exam). [1] Cotton wool spots are typically a sign of another disease state, most common of which is diabetic retinopathy. [2] The irregularly shaped white patches are a result of ischemia, or reduced blood flow and oxygen, in the retinal nerve fiber layer, which is located in the distribution of the capillaries of the superficial layer of the retina. [2] These areas with reduced blood flow reflect the obstruction of axoplasmic flow due to mechanical or vascular causes and the consequential accumulation as a result of decreased axonal transport. [1] [2] This reduced axonal transport can then cause swelling or bulging on the surface layer of the retina, increasing the potential for nerve fiber damage. [2]

Contents

The presence of cotton wool spots may resolve independently over time, typically in 4–12 weeks, or may depend on the underlying disease causing the condition. [3] [4] Diagnosis and treatment of the underlying disease state may be beneficial in the treatment and management of cotton wool spots. [3]

Signs and symptoms

Cotton wool spots present as opaque fluffy white spots, sometimes with feather-like edges, on the retina when seen on a funduscopic exam. [1] [2] These opaque white areas are typically asymptomatic, but may cause some vision loss due to the underlying disease state. [5] Cotton wool spots are a retinal condition that when present, frequently act as a significant indicator, or sign, of a variety of underlying disease states. These fluffy white spots are often accompanied by additional abnormal funduscopic findings such as intraretinal bleeds, hard exudates, and atypical small blood vessels, including obstructed or dilated blood vessels and microaneurysms. [6] These associated findings are common due to the underlying diseases causing these manifestations seen in the eyes. Because of the use of cotton wool spots more as an indicator of other systemic diseases, Mcleod had proposed that the taxonomy of the terms 'cotton wool spot' should be changed to something else to help better understand its true meaning. [7]

Pathophysiology

Cotton wool spots are commonly caused by changes to the retina secondary to diabetes, hypertension, or blockages to blood vessels to the retina, such as central retinal vein occlusion. [5] [8] While at one point believed to have been the result of nerve damage in the retina, interruptions to axoplasmic flow to these nerves may result from organelle accumulation in the axons. [7] This is further purported by the presence of cytoid bodies in ganglion axon cells, where the accumulation of white blood cells, more specifically, eosinophils, mitochondria, and other cellular material lead to swelling of the ganglion axon cells which then lead to cotton wool spots. [9]

Causes

Referred to as a form of retinal myopathies, cotton wools spots are commonly found to be a secondary manifestation to diseases like diabetes, hypertension, and AIDS. [1] Cotton wool spots have become one of the hallmarks of pre-proliferative diabetic retinopathy, a condition caused by damaged blood vessels in the retina due to high blood sugar. [10] Abundant cotton wool spots are also found in hypertensive retinopathy, including malignant hypertension, where the white patches are a result of a microvascular infarct, or a sudden occlusion of the arteriole. [2] One study observed the presence of cotton wool spots in people with acute leukemia, referring to the increase in white blood cells as a probable cause. [11] Although cotton wool spots are a secondary manifestation to leukemia, they have been found to be a poor prognostic sign for survival in acute leukemia. [12]

Diabetic retinopathy occurs when long standing diabetes begins to damage blood vessels in the eyes which leads to leakages in the eyes, known as hemorrhages and the appearance of yellow-white spots known as cotton wool spots. A sample retinal image with cotton wool spots and hemorrhages.png
Diabetic retinopathy occurs when long standing diabetes begins to damage blood vessels in the eyes which leads to leakages in the eyes, known as hemorrhages and the appearance of yellow-white spots known as cotton wool spots.

More recently, prolonged travel in space has been found to be a probable cause of cotton wool spots in people who experience ocular changes after coming back from space. [14] Although infrequent, conditions like HIV and Purtscher's retinopathy can also lead to the appearance of cotton wool spots. [2] Although they are associated with multiple systemic diseases, it is possible for there to be an unknown etiology that would require further investigation. [15] Cotton wool spots have different clinical characteristics when present as a result of HIV rather than in systemic diseases, like diabetes or hypertension, due to the viral complexes that cause structural changes to the retinal microvasculature. [3]

Cotton wool spots are also associated with giant cell arteritis (GCA), a type of inflammation of the lining of the arteries, as this may reduce blood flow to the eyes. [1] In a study of 123 subjects with vision loss due to early stage giant cell arteritis, one-third of subjects had cotton wool spots present in their eyes. [2] Furthermore, because giant cell arteritis can lead to loss of vision and is associated with cotton wool spots, it is recommended to investigate for giant cell arteritis if cotton wool spots are found. [1]

Another condition in which cotton wool spots are found is central retinal vein occlusion [7] as a result of reduced blood flow from retinal arteriole obstruction. [5]

A study conducted at Wills Eye Hospital in Pennsylvania found that a potential side effect of medications like macitentan, an endothelin receptor antagonist that is used to treat pulmonary arterial hypertension, can be bilateral cotton wool spots. [16] As such, if a person develops cotton wool spots after starting an endothelin receptor antagonist, medication side effect should be considered as a plausible cause.

Possible causes

Cladribine

While still an ongoing and recent investigation, cladribine use can also be associated with the development of cotton wool spots. Cladribine, also known by its brand name Mavenclad, is a purine antimetabolite and antineoplastic drug used to reduce relapse rates and slow down disease progression for people with relapsing forms of multiple sclerosis in those who have not benefitted from or were unable to use other drugs multiple sclerosis. In a case study of a 39-year-old female with a history of relapsing forms of multiple sclerosis, after four years of using fingolimod (also known by its brand name Gilenya), another drug used to treat relapsing forms of multiple sclerosis, she was switched to cladribine. On day five of her second cycle of cladribine, she reported a shadow in her right eye, of which on day seven during an eye exam a cotton wool spot was found in the same eye. Six weeks after completing the second cycle of cladribine, the reported cotton wool spot was still present albeit reduced in size. At the 12-week mark, her vision returned to normal and the cotton wool spot was undetectable after 10 months. The study postulates the possibility that cladribine use may cause cotton wool spots due to its side effects of lymphopenia, neutropenia, thrombocytopenia, pancytopenia, and infections as well as the timing of the formation of cotton wool spots in line with cladribine use in a person who otherwise had no risk factors for cotton wool spots as well as the resolution of cotton wool spots once off cladribine for an extended period of time. [17]

Chronic migraines

Another proposed associated cause of cotton wool spots is chronic migraines. In a study of four subjects, two male and two female, with chronic migraines and no other present risk factors for cotton wool spots, such as normal hemoglobin A1C and blood glucose (indicating no diabetic risk), no indicators of being immunocompromised, and having blood pressures under 140/90 mm Hg (no chronic hypertension), presented with cotton wool spots in one of their eyes. Since no other risk factors were present and the common factor between the four subjects was chronic migraines, the study postulates that vasospastic syndromes common in those with chronic migraines may lead to ischemia in the eyes leading to the formation of cotton wool spots, as cotton wool spots can also act as an indicator of general vasospastic activity. [18]

As there are many causes of cotton wool spots, oftentimes ophthalmologists will convey the findings to the person's primary health care provider and emphasize that the appearance of cotton wool spots may need workup to investigate the root cause and proper treatment pathway.

Diagnosis

Cotton wool spots have two different types of ways to differentiate between other disease states or conditions that contribute to the same outcomes. One of the ways, takes account for all the conditions that are present in the eye that may actually look like cotton wool spots. The second way takes account for the root cause or causes of the cotton wool spots.

To ensure proper etiology and diagnosis, those presenting with symptoms would require a thorough history and eye exam which includes dilated retinal evaluation. Depending on the findings, a person may require further workup including blood tests to explore other potential causes. The blood work may include a complete blood count, basic metabolic panel, digestive enzymes such as amylase and lipase, and even several blood pressure measurements. [19] Another method of diagnosis or screening is through the use of spectral domain optical coherence tomography (SD-OCT) which follows the cotton wool spots and their progression. [1] The emergence of advanced technological tools like SD-OCT are providing new insight of neurosensory retinal health in vivo, especially in cases such as analysis of the retina post-resolution of cotton wool spots. [1]

However, funduscopic exams that find patchy opaque areas on the retina may misdiagnose the condition as cotton wool spots instead of transient branch retinal artery occlusion (BRAO) which also does not effect vision and self-resolves. [2]

Treatment and management

Currently there are no direct treatments for cotton wool spots, however, they may fade away or disappear completely on their own in about 6 to 12 weeks. The duration of cotton wool spots typically depends on the underlying disease state that caused the cotton wool spots to appear. [20] For example, cotton wool spots appear much smaller in HIV/AIDS in comparison to the cotton wool spots that appear in diabetes. [20] Although, the difference in duration or half-life of the cotton wool spots may be a result of differing demographics that are affected by the underlying diseases and the overall health of the retinal vessels affected. [3] In addition, it is thought that age may play a factor for the duration of cotton wool spots in diabetic patients. In one study, cotton wool spots were found to have a shorter duration in diabetic patients under forty years old compared to the cotton wool spots in diabetic patients over forty years old. [21] Although there is no direct treatment of cotton wool spots, targeting the underlying origin of the disease can be beneficial in treating the cotton wool spots. [5] [22]

While in the acute phase, the fluorescent funduscopy exam shows obstruction of retinal capillaries in the area of the cotton wool spots. Once these areas of opacity resolve and the retina evaluation returns to normal, a fluorescent angiography is performed to determine lasting damage to the obstructed retinal capillaries. [2] The severity of the cotton wool spots is the major determining factor in the extent of lasting capillary damage. [2] Following the resolution of cotton wool spots, visual function does not typically recover, although cases of recovery have been documented. [1] The exact mechanics of visual recovery is mostly unknown, but may be associated with the survival of enough ganglion axon cells to meet a necessary threshold for vision to successfully recover. [1]

See also

Related Research Articles

<span class="mw-page-title-main">Retinopathy</span> Medical condition

Retinopathy is any damage to the retina of the eyes, which may cause vision impairment. Retinopathy often refers to retinal vascular disease, or damage to the retina caused by abnormal blood flow. Age-related macular degeneration is technically included under the umbrella term retinopathy but is often discussed as a separate entity. Retinopathy, or retinal vascular disease, can be broadly categorized into proliferative and non-proliferative types. Frequently, retinopathy is an ocular manifestation of systemic disease as seen in diabetes or hypertension. Diabetes is the most common cause of retinopathy in the U.S. as of 2008. Diabetic retinopathy is the leading cause of blindness in working-aged people. It accounts for about 5% of blindness worldwide and is designated a priority eye disease by the World Health Organization.

<span class="mw-page-title-main">Diabetic retinopathy</span> Medical condition

Diabetic retinopathy, is a medical condition in which damage occurs to the retina due to diabetes. It is a leading cause of blindness in developed countries.

<span class="mw-page-title-main">Hypertensive retinopathy</span> Medical condition

Hypertensive retinopathy is damage to the retina and retinal circulation due to high blood pressure.

<span class="mw-page-title-main">Macular edema</span> Medical condition

Macular edema occurs when fluid and protein deposits collect on or under the macula of the eye and causes it to thicken and swell (edema). The swelling may distort a person's central vision, because the macula holds tightly packed cones that provide sharp, clear, central vision to enable a person to see detail, form, and color that is directly in the centre of the field of view.

<span class="mw-page-title-main">Amaurosis fugax</span> Medical condition

Amaurosis fugax is a painless temporary loss of vision in one or both eyes.

Retinal hemorrhage is a disorder of the eye in which bleeding occurs in the retina, the light sensitive tissue, located on the back wall of the eye. There are photoreceptor cells in the retina called rods and cones, which transduce light energy into nerve signals that can be processed by the brain to form visual images. Retinal hemorrhage is strongly associated with child abuse in infants and young children and often leaves such abused infants permanently blind. In older children and adults, retinal hemorrhage can be caused by several medical conditions such as hypertension, retinal vein occlusion, anemia, leukemia or diabetes.

<span class="mw-page-title-main">Electroretinography</span>

Electroretinography measures the electrical responses of various cell types in the retina, including the photoreceptors, inner retinal cells, and the ganglion cells. Electrodes are placed on the surface of the cornea or on the skin beneath the eye to measure retinal responses. Retinal pigment epithelium (RPE) responses are measured with an EOG test with skin-contact electrodes placed near the canthi. During a recording, the patient's eyes are exposed to standardized stimuli and the resulting signal is displayed showing the time course of the signal's amplitude (voltage). Signals are very small, and typically are measured in microvolts or nanovolts. The ERG is composed of electrical potentials contributed by different cell types within the retina, and the stimulus conditions can elicit stronger response from certain components.

Neovascularization is the natural formation of new blood vessels, usually in the form of functional microvascular networks, capable of perfusion by red blood cells, that form to serve as collateral circulation in response to local poor perfusion or ischemia.

<span class="mw-page-title-main">Dilated fundus examination</span>

Dilated fundus examination (DFE) is a diagnostic procedure that uses mydriatic eye drops to dilate or enlarge the pupil in order to obtain a better view of the fundus of the eye. Once the pupil is dilated, examiners use ophthalmoscopy to view the eye's interior, which makes it easier to assess the retina, optic nerve head, blood vessels, and other important features. DFE has been found to be a more effective method for evaluating eye health when compared to non-dilated examination, and is the best method of evaluating structures behind the iris. It is frequently performed by ophthalmologists and optometrists as part of an eye examination.

Ocular ischemic syndrome is the constellation of ocular signs and symptoms secondary to severe, chronic arterial hypoperfusion to the eye. Amaurosis fugax is a form of acute vision loss caused by reduced blood flow to the eye; it may be a warning sign of an impending stroke, as both stroke and retinal artery occlusion can be caused by thromboembolism due to atherosclerosis elsewhere in the body. Consequently, those with transient blurring of vision are advised to urgently seek medical attention for a thorough evaluation of the carotid artery. Anterior segment ischemic syndrome is a similar ischemic condition of anterior segment usually seen in post-surgical cases. Retinal artery occlusion leads to rapid death of retinal cells, thereby resulting in severe loss of vision.

Central retinal artery occlusion (CRAO) is a disease of the eye where the flow of blood through the central retinal artery is blocked (occluded). There are several different causes of this occlusion; the most common is carotid artery atherosclerosis.

<span class="mw-page-title-main">Blurred vision</span> Medical condition

Blurred vision is an ocular symptom where vision becomes less precise and there is added difficulty to resolve fine details.

<span class="mw-page-title-main">Retinal migraine</span> Medical condition

Retinal migraine is a retinal disease often accompanied by migraine headache and typically affects only one eye. It is caused by ischaemia or vascular spasm in or behind the affected eye.

<span class="mw-page-title-main">Laser coagulation</span> Procedure widely used in eye surgery

Laser coagulation or laser photocoagulation surgery is used to treat a number of eye diseases and has become widely used in recent decades. During the procedure, a laser is used to finely cauterize ocular blood vessels to attempt to bring about various therapeutic benefits.

<span class="mw-page-title-main">Purtscher's retinopathy</span> Medical condition

Purtscher's retinopathy is a disease where part of the eye (retina) is damaged. Usually associated with severe head injuries, it may also occur with other types of trauma, such as long bone fractures, or with several non-traumatic systemic diseases. However, the exact cause of the disease is not well understood. There are no treatments specific for Purtscher's retinopathy, and the prognosis varies. The disease can threaten vision, sometimes causing temporary or permanent blindness.

<span class="mw-page-title-main">Retinal vasculitis</span> Medical condition

Retinal vasculitis is inflammation of the vascular branches of the retinal artery, caused either by primary ocular disease processes, or as a specific presentation of any systemic form of vasculitis such as Behçet's disease, sarcoidosis, multiple sclerosis, or any form of systemic necrotizing vasculitis such as temporal arteritis, polyarteritis nodosa, and granulomatosis with polyangiitis, or due to lupus erythematosus, or rheumatoid arthritis. Eales disease, pars planitis, birdshot retinochoroidopathy, and Fuchs heterochromic iridocyclitis (FHI) can also cause retinal vasculitis. Infectious pathogens such as Mycobacterium tuberculosis, visceral larva migrans can also cause retinal vasculitis. Drug-induced vasculitis may involve retina as well, as seen in methamphetamine induced vasculitis.

Optical coherence tomography angiography (OCTA) is a non-invasive imaging technique based on optical coherence tomography (OCT) developed to visualize vascular networks in the human retina, choroid, skin and various animal models. OCTA may make use of speckle variance optical coherence tomography.

<span class="mw-page-title-main">Intravitreal injection</span> Method of administration of drugs into the eye by injection with a fine needle

Intravitreal injection is the method of administration of drugs into the eye by injection with a fine needle. The medication will be directly applied into the vitreous humor. It is used to treat various eye diseases, such as age-related macular degeneration (AMD), diabetic retinopathy, and infections inside the eye such as endophthalmitis. As compared to topical administration, this method is beneficial for a more localized delivery of medications to the targeted site, as the needle can directly pass through the anatomical eye barrier and dynamic barrier. It could also minimize adverse drug effects on other body tissues via the systemic circulation, which could be a possible risk for intravenous injection of medications. Although there are risks of infections or other complications, with suitable precautions throughout the injection process, chances for these complications could be lowered.

Sickle cell retinopathy can be defined as retinal changes due to blood vessel damage in the eye of a person with a background of sickle cell disease. It can likely progress to loss of vision in late stages due to vitreous hemorrhage or retinal detachment. Sickle cell disease is a structural red blood cell disorder leading to consequences in multiple systems. It is characterized by chronic red blood cell destruction, vascular injury, and tissue ischemia causing damage to the brain, eyes, heart, lungs, kidneys, spleen, and musculoskeletal system.

Drug abuse retinopathy is damage to the retina of the eyes caused by chronic drug abuse. Types of retinopathy caused by drug abuse include maculopathy, Saturday night retinopathy, and talc retinopathy. Common symptoms include temporary and permanent vision loss, blurred vision, and night blindness. Substances commonly associated with this condition include poppers, heroin, cocaine, methamphetamine, tobacco, and alcohol.

References

  1. 1 2 3 4 5 6 7 8 9 10 Ioannides A, Georgakarakos ND, Elaroud I, Andreou P (2011). "Isolated cotton-wool spots of unknown etiology: management and sequential spectral domain optical coherence tomography documentation". Clinical Ophthalmology. 5: 1431–1433. doi: 10.2147/OPTH.S16272 . PMC   3198419 . PMID   22034565.
  2. 1 2 3 4 5 6 7 8 9 10 11 Hayreh SS (September 2011). "Acute retinal arterial occlusive disorders". Progress in Retinal and Eye Research. 30 (5): 359–394. doi:10.1016/j.preteyeres.2011.05.001. PMC   3137709 . PMID   21620994.
  3. 1 2 3 4 Gomez ML, Mojana F, Bartsch DU, Freeman WR (December 2009). "Imaging of long-term retinal damage after resolved cotton wool spots". Ophthalmology. 116 (12): 2407–2414. doi:10.1016/j.ophtha.2009.05.012. PMC   4172325 . PMID   19815278.
  4. Schmidt D (June 2008). "The mystery of cotton-wool spots - a review of recent and historical descriptions". European Journal of Medical Research. 13 (6): 231–266. PMID   18558551.
  5. 1 2 3 4 Patel PS, Sadda SR (2013). "Retinal Artery Obstructions". Retina. Elsevier: 1012–1025. doi:10.1016/b978-1-4557-0737-9.00051-5. ISBN   978-1-4557-0737-9.
  6. Hendrick AM, Gibson MV, Kulshreshtha A (September 2015). "Diabetic Retinopathy". Primary Care. 42 (3): 451–464. doi:10.1016/j.pop.2015.05.005. PMID   26319349.
  7. 1 2 3 McLeod D (February 2005). "Why cotton wool spots should not be regarded as retinal nerve fibre layer infarcts". The British Journal of Ophthalmology. 89 (2). BMJ Group: 229–237. doi:10.1136/bjo.2004.058347. PMC   1772507 . PMID   15665358.
  8. Terelak-Borys B, Skonieczna K, Grabska-Liberek I (August 2012). "Ocular ischemic syndrome - a systematic review". Medical Science Monitor. 18 (8): RA138–RA144. doi:10.12659/msm.883260. PMC   3560693 . PMID   22847215.
  9. Eagle Jr RC (2011). Eye pathology an atlas and text (2nd ed.). Philadelphia: Lippincott Williams & Wilkins.
  10. Yanoff M, Duker JS, Augsburger JJ (2009). Ophthalmology (3rd ed.). [Edinburgh]: Mosby Elsevier. ISBN   978-0-323-04332-8. OCLC   299238877.
  11. Yassin MA, Ata F, Mohamed SF, Alkhateeb A, Naeem U, Al-Qatami AI, et al. (2022). "Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A review". Survey of Ophthalmology. 67 (2): 530–543. doi:10.1016/j.survophthal.2021.07.001. PMID   34252423. S2CID   235809155.
  12. Abu el-Asrar AM, al-Momen AK, Kangave D, Harakati MS (1996). "Prognostic importance of retinopathy in acute leukemia". Documenta Ophthalmologica. Advances in Ophthalmology. 91 (3): 273–281. doi:10.1007/BF01204178. PMID   8886591. S2CID   6780249.
  13. Besenczi R, Tóth J, Hajdu A (2016). "A review on automatic analysis techniques for color fundus photographs". Computational and Structural Biotechnology Journal. 14: 371–384. doi:10.1016/j.csbj.2016.10.001. PMC   5072151 . PMID   27800125.
  14. Khossravi EA, Hargens AR (January 2021). "Visual disturbances during prolonged space missions". Current Opinion in Ophthalmology. 32 (1): 69–73. doi:10.1097/ICU.0000000000000724. PMID   33196542. S2CID   226988185.
  15. Bhatt A, Nguyen C, Mosaed S, Minckler D (June 2018). "Clinical and pathological correlation of cotton wool spots in secondary angle closure glaucoma". American Journal of Ophthalmology Case Reports. 10: 192–195. doi:10.1016/j.ajoc.2018.02.028. PMC   5956715 . PMID   29780936.
  16. Khan MA, Ho AC, Spirn MJ (2017). "Cotton-Wool Spots After Use of Macitentan for Pulmonary Arterial Hypertension". Retinal Cases & Brief Reports. 11 (1): 4–6. doi:10.1097/ICB.0000000000000273. PMID   26829448. S2CID   10042977.
  17. Gummi R, Walsh RD, Ahmad B (February 2021). "Retinal cotton wool spot associated with cladribine therapy for multiple sclerosis". Multiple Sclerosis and Related Disorders. 48: 102661. doi:10.1016/j.msard.2020.102661. PMID   33321344. S2CID   229283000.
  18. Yuan PH, Micieli JA (August 2022). "Cotton-wool spots in patients with migraine". Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie. 57 (4): e133–e135. doi: 10.1016/j.jcjo.2021.11.006 . PMID   34921768.
  19. Nika B, Wajda BN (2017). The Wills eye manual: office and emergency room diagnosis and treatment of eye disease (7th ed.). Philadelphia, PA. ISBN   978-1-4963-5366-5. OCLC   951081880.{{cite book}}: CS1 maint: location missing publisher (link)
  20. 1 2 Mansour AM, Jampol LM, Logani S, Read J, Henderly D (August 1988). "Cotton-wool spots in acquired immunodeficiency syndrome compared with diabetes mellitus, systemic hypertension, and central retinal vein occlusion". Archives of Ophthalmology. 106 (8): 1074–1077. doi:10.1001/archopht.1988.01060140230030. PMID   3401133.
  21. Mansour AM, Rodenko G, Dutt R (March 1990). "Half-life of cotton-wool spots in the acquired immunodeficiency syndrome". International Journal of STD & AIDS. 1 (2): 132–133. doi:10.1177/095646249000100213. PMID   2092789. S2CID   41543770.
  22. Ulbig M (2008). "The Wills Eye Manual Office and Emergency Room Diagnosis and Treatment of Eye Disease Fifth Edition Eds: Justis P. Ehlers and Chirag P. Shah 2008 ISBN: 978-0-7817-6962-4 Lippincott Williams & Wilkins". Graefe's Archive for Clinical and Experimental Ophthalmology. 247 (11): 1579. doi: 10.1007/s00417-008-0966-5 . ISSN   0721-832X. S2CID   29883767.